(Press-News.org) Scientists have found that bacteria have the potential to teach valuable investment lessons. The research, published in the journal Ecology Letters, takes advantage of the fact that bacteria, like humans, have limited resources and are constantly faced with investment decisions. Bacteria though are successful with their investments and have colonised every inch of the surface of our planet.
The researchers, from the Universities of Exeter and Sydney, used mathematical models and lab-based synthetic biology, to predict bacterial investment crashes and boom-bust cycles. The study reveals how the diversity of life we see around us is maintained and demonstrates that the outcomes of investment decisions can be precisely defined. It explains why a single-celled, fat cat investor didn't win out long ago.
The scientists developed the mathematical model to predict the best way for bacteria to invest resources in a trade-off between growth and investment in stress resistance. While humans invest in cash, bacteria trade in costly proteins to reduce their stress levels or to increase consumption and so grow faster. Evolution is the decision making process with different choices encoded in the genes. Each bacterium makes an investment decision; the bad investors fall by the wayside, the good ones survive.
A set of strains of E. coli bacteria were created which had a broad range of abilities to deal with stress and invest in growth; those that were better at stress were worse at investing in growth. The bacteria were exposed to stress conditions – salt and acid – representing different market conditions. This allowed the researchers to precisely define, for the first time, the exact nature of the bacterial trade-offs seen in the lab.
Co-author Dr Tom Ferenci from the University of Sydney said: "The breakthrough was in using synthetic biology to create bacteria with different investment strategies, some investing in growth and others in stress resistance. This is the cleanest system yet that precisely defines a relationship between traded objects in a living 'market'."
Co-author Dr Ivana Gudelj from the University of Exeter added: "Combining engineered bacteria with mathematical models, we have shown that very similar investment opportunities can require different investment strategies. These strategies are constrained by the subtleties in trade-offs that are usually invisible or ignored in real markets. The study is a classic demonstration of Darwinian economics and survival of the fittest."
It has been believed for decades that trade-offs in the decision-making process give biological investors different niches to exploit as is the case in evolutionary decisions but until now, no-one has been able to prove or disprove it.
Dan Lovallo, Professor of Business Strategy at the University of Sydney and senior research fellow at the Institute for Innovation Management and Organization at the University of California, Berkeley, who was not involved in the research, said: "This paper breaks exciting new ground in the integration of the sciences and provides compelling new evidence on resource allocation that will be of interest to multiple fields: economics, finance, business strategy, and biology."
###
This research was funded by Natural Environment Research Council (NERC), the Biotechnology and Biosciences Research Council (BBSRC), the Engineering and Physical Sciences Research Council (EPSRC) and the Australian Research Council.
About the University of Exeter
The Sunday Times University of the Year 2012-13, the University of Exeter is a Russell Group university and in the top one percent of institutions globally. It combines world-class research with very high levels of student satisfaction. Exeter has over 18,000 students and is ranked 7th in The Sunday Times University Guide, 10th in The Complete University Guide, 10th in the UK in The Times Good University Guide 2012 and 12th in the Guardian University Guide 2014. In the 2008 Research Assessment Exercise (RAE) 90% of the University's research was rated as being at internationally recognised levels and 16 of its 31 subjects are ranked in the top 10, with 27 subjects ranked in the top 20.
The University has invested strategically to deliver more than £350 million worth of new facilities across its campuses in the last few years; including landmark new student services centres - the Forum in Exeter and The Exchange on the Penryn Campus in Cornwall, together with world-class new facilities for Biosciences, the Business School and the Environment and Sustainability Institute. There are plans for another £330 million of investment between now and 2016.
http://www.exeter.ac.uk
For further information:
Dr Jo Bowler
University of Exeter Press Office
Office: +44 (0)1392 722062
Mobile: +44(0)7827 309 332
Twitter: @UoE_ScienceNews
j.bowler@exeter.ac.uk
About BBSRC
The Biotechnology and Biological Sciences Research Council (BBSRC) invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.
Funded by Government, and with an annual budget of around £467M (2012-2013), we support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.
For more information about BBSRC, our science and our impact see: http://www.bbsrc.ac.uk
For more information about BBSRC strategically funded institutes see: http://www.bbsrc.ac.uk/institutes
Bacteria hold the clues to trade-offs in financial investments and evolution
2013-08-01
ELSE PRESS RELEASES FROM THIS DATE:
UC San Diego researchers develop efficient model for generating human iPSCs
2013-08-01
Researchers at the University of California, San Diego School of Medicine report a simple, easily reproducible RNA-based method of generating human induced pluripotent stem cells (iPSCs) in the August 1 edition of Cell Stem Cell. Their approach has broad applicability for the successful production of iPSCs for use in human stem cell studies and eventual cell therapies.
Partially funded by grants from the California Institute for Regenerative Medicine (CIRM) and the National Institutes of Health (NIH), the methods developed by the UC San Diego researchers dramatically ...
Fly study finds 2 new drivers of RNA editing
2013-08-01
PROVIDENCE, R.I. [Brown University] — RNA editing gives organisms a way to adapt the instructions that their DNA provides for making proteins. Few people would have described RNA editing as a simple process, but a new paper in Nature Communications demonstrates the process as more complex and difficult to predict than previously assumed. The study, done in living fruit flies, discovered two new mechanisms that govern editing in a key neurodevelopmental gene.
RNA editing is governed not only by sequences of RNA nucleotides (the letters A, C, G, and U) and corresponding ...
Ultrasound patch heals venous ulcers in human trial
2013-08-01
In a small clinical study, researchers administered a new method for treating chronic wounds using a novel ultrasound applicator that can be worn like a band-aid. The applicator delivers low-frequency, low-intensity ultrasound directly to wounds, and was found to significantly accelerate healing in five patients with venous ulcers. Venous ulcers are caused when valves in the veins malfunction, causing blood to pool in the leg instead of returning to the heart. This pooling, called venous stasis, can cause proteins and cells in the vein to leak into the surrounding tissue ...
New designer compound treats heart failure by targeting cell nucleus
2013-08-01
Researchers from Case Western Reserve University School of Medicine and the Dana-Farber Cancer Institute have made a fundamental discovery relevant to the understanding and treatment of heart failure – a leading cause of death worldwide. The team discovered a new molecular pathway responsible for causing heart failure and showed that a first-in-class prototype drug, JQ1, blocks this pathway to protect the heart from damage.
In contrast to standard therapies for heart failure, JQ1 works directly within the cell's command center, or nucleus, to prevent damaging stress responses. ...
When galaxies switch off
2013-08-01
Some galaxies hit a point in their lives when their star formation is snuffed out, and they become "quenched". Quenched galaxies in the distant past appear to be much smaller than the quenched galaxies in the Universe today. This has always puzzled astronomers -- how can these galaxies grow if they are no longer forming stars? A team of astronomers has now used a huge set of Hubble observations to give a surprisingly simple answer to this long-standing cosmic riddle.
Until now, these small, snuffed-out galaxies were thought to grow into the larger quenched galaxies we ...
Nice organisms finish first: Why cooperators always win in the long run
2013-08-01
Leading physicists last year turned game theory on its head by giving selfish players a sure bet to beat cooperative players. Now two evolutionary biologists at Michigan State University offer new evidence that the selfish will die out in the long run.
"We found evolution will punish you if you're selfish and mean," said lead author Christoph Adami, MSU professor of microbiology and molecular genetics. "For a short time and against a specific set of opponents, some selfish organisms may come out ahead. But selfishness isn't evolutionarily sustainable."
The paper "Evolutionary ...
Potential nutritional therapy for childhood neurodegenerative disease
2013-08-01
Researchers at the University of California, San Diego School of Medicine have identified the gene mutation responsible for a particularly severe form of pontocerebellar hypoplasia, a currently incurable neurodegenerative disease affecting children. Based on results in cultured cells, they are hopeful that a nutritional supplement may one day be able to prevent or reverse the condition.
The study, from a team of international collaborators led by Joseph G. Gleeson, MD – Howard Hughes Medical Institute investigator and professor in the UCSD Departments of Neurosciences ...
A week's worth of camping synchs internal clock to sunrise and sunset, CU-Boulder study finds
2013-08-01
Spending just one week exposed only to natural light while camping in the Rocky Mountains was enough to synch the circadian clocks of eight people participating in a University of Colorado Boulder study with the timing of sunrise and sunset.
The study, published online today in the journal Current Biology, found that the synchronization happened in that short period of time for all participants, regardless of whether they were early birds or night owls during their normal lives.
"What's remarkable is how, when we're exposed to natural sunlight, our clocks perfectly ...
Stray prenatal gene network suspected in schizophrenia
2013-08-01
Researchers have reverse-engineered the outlines of a disrupted prenatal gene network in schizophrenia, by tracing spontaneous mutations to where and when they likely cause damage in the brain. Some people with the brain disorder may suffer from impaired birth of new neurons, or neurogenesis, in the front of their brain during prenatal development, suggests the study, which was funded by the National Institutes of Health.
"Processes critical for the brain's development can be revealed by the mutations that disrupt them," explained Mary-Claire King, Ph.D., University ...
New target for the fight against cancer as a result of excessive blood vessel formation
2013-08-01
New blood vessel formation (angiogenesis) stimulates the growth of cancer and other diseases. Anti-angiogenic inhibitors slow down cancer growth by disrupting the blood supply to the tumor. To date, the success of these treatments is limited by resistance, poor efficiency and harmful side effects. In the leading scientific journal Cell, Peter Carmeliet (VIB-KU Leuven) and his team reported that sugar metabolism (a process that we call glycolysis) also plays an essential role in the formation of new blood vessels. These totally revolutionary insights open up many new therapeutic ...